Thomas Flaten
Stock Analyst at Lake Street
(1.04)
# 3,487
Out of 4,829 analysts
39
Total ratings
31.58%
Success rate
-15.1%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintains: Buy | $40 → $35 | $16.81 | +108.21% | 6 | May 6, 2025 | |
| OCX OncoCyte | Initiates: Buy | $5 | $2.87 | +74.22% | 5 | Mar 28, 2025 | |
| OPTN OptiNose | Downgrades: Hold | $17 → $9 | $9.39 | -4.15% | 5 | Mar 20, 2025 | |
| CKPT Checkpoint Therapeutics | Downgrades: Hold | $7 → $4.1 | $4.18 | -1.80% | 5 | Mar 10, 2025 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $8 | $2.79 | +186.74% | 2 | Mar 7, 2025 | |
| EVAX Evaxion Biotech | Maintains: Buy | $35 → $6 | $1.49 | +302.68% | 2 | Feb 4, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $9 | $5.04 | +78.57% | 2 | Jan 8, 2025 | |
| DERM Journey Medical | Initiates: Buy | $9 | $6.88 | +30.81% | 1 | Sep 6, 2024 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $0.61 | +391.80% | 3 | Mar 12, 2024 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $19 → $11 | $2.35 | +369.08% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $23.29 | +7.34% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $2.17 | +66,259.45% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $3.66 | +118.58% | 1 | Jul 7, 2022 |
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $16.81
Upside: +108.21%
OncoCyte
Mar 28, 2025
Initiates: Buy
Price Target: $5
Current: $2.87
Upside: +74.22%
OptiNose
Mar 20, 2025
Downgrades: Hold
Price Target: $17 → $9
Current: $9.39
Upside: -4.15%
Checkpoint Therapeutics
Mar 10, 2025
Downgrades: Hold
Price Target: $7 → $4.1
Current: $4.18
Upside: -1.80%
Aquestive Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $2.79
Upside: +186.74%
Evaxion Biotech
Feb 4, 2025
Maintains: Buy
Price Target: $35 → $6
Current: $1.49
Upside: +302.68%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $5.04
Upside: +78.57%
Journey Medical
Sep 6, 2024
Initiates: Buy
Price Target: $9
Current: $6.88
Upside: +30.81%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.61
Upside: +391.80%
Achieve Life Sciences
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $2.35
Upside: +369.08%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $23.29
Upside: +7.34%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $2.17
Upside: +66,259.45%
Jul 7, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $3.66
Upside: +118.58%